• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肺表面活性蛋白 SP-D 的超分子组装。

Supramolecular Assembly of Human Pulmonary Surfactant Protein SP-D.

机构信息

Department of Biochemistry, Faculty of Biology, Complutense University, 28040 Madrid, Spain; Research Institut "Hospital 2 de Octubre (imas12)", 28040 Madrid, Spain.

Department of Macromolecular Structures, National Center of Biotechnology, CSIC, 28049 Madrid, Spain.

出版信息

J Mol Biol. 2018 May 11;430(10):1495-1509. doi: 10.1016/j.jmb.2018.03.027. Epub 2018 Apr 4.

DOI:10.1016/j.jmb.2018.03.027
PMID:29626540
Abstract

Pulmonary surfactant protein D (SP-D) is a glycoprotein from the collectin family that is a component of the lung surfactant system. It exhibits host defense and immune regulatory functions in addition to contributing to the homeostasis of the surfactant pool within the alveolar airspaces. It is known that the SP-D monomer forms trimers, which further associate into higher-order oligomers. However, the pathway and the interactions involved in the assembly of SP-D oligomers are not clearly understood. In the current study, a recombinant form of full-length human SP-D (rhSP-D) has been qualitatively and quantitatively studied by atomic force microscopy (AFM) and electrophoresis, with the aim to understand the conformational diversity and the determinants defining the oligomerization of the protein. The rhSP-D preparation studied is a mixture of trimers, hexamers, dodecamers and higher-order oligomeric species, with dodecamers accounting for more than 50% of the protein by mass. Similar structures were also found in hSP-D obtained from proteinosis patients, with the largest fuzzy-ball-like oligomers being more abundant in these samples. The proportion of dodecamer is increased under acidic conditions, accompanied by a conformational change into more compact configurations. Two hexamers appear to be the minimal necessary unit for dodecamer formation, with stabilization of the dodecamer occurring via non-covalent, ionic, and hydrophobic interactions between the individual N-terminal domains and the proximal area of the SP-D collagen stems.

摘要

肺表面活性物质蛋白 D(SP-D)是一种来自凝集素家族的糖蛋白,是肺表面活性物质系统的组成部分。除了有助于肺泡气腔中表面活性物质池的动态平衡外,它还具有宿主防御和免疫调节功能。已知 SP-D 单体形成三聚体,这些三聚体进一步缔合成更高阶的寡聚物。然而,SP-D 寡聚物组装的途径和相互作用尚不清楚。在本研究中,通过原子力显微镜(AFM)和电泳对全长人 SP-D(rhSP-D)的重组形式进行了定性和定量研究,旨在了解该蛋白的构象多样性和决定其寡聚化的因素。所研究的 rhSP-D 制剂是三聚体、六聚体、十二聚体和更高阶寡聚体的混合物,按质量计,十二聚体占蛋白质的 50%以上。在来自蛋白病患者的 hSP-D 中也发现了类似的结构,这些样品中最大的模糊球样寡聚物更为丰富。在酸性条件下,十二聚体的比例增加,同时构象发生变化,变得更加紧凑。两个六聚体似乎是形成十二聚体的最小必需单位,通过单体的 N 端结构域和 SP-D 胶原主干近端区域之间的非共价、离子和疏水相互作用稳定十二聚体的形成。

相似文献

1
Supramolecular Assembly of Human Pulmonary Surfactant Protein SP-D.人肺表面活性蛋白 SP-D 的超分子组装。
J Mol Biol. 2018 May 11;430(10):1495-1509. doi: 10.1016/j.jmb.2018.03.027. Epub 2018 Apr 4.
2
Functional characterization of the different oligomeric forms of human surfactant protein SP-D.人表面活性蛋白 D 的不同寡聚形式的功能特征。
Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140436. doi: 10.1016/j.bbapap.2020.140436. Epub 2020 Apr 20.
3
Structure and activity of human surfactant protein D from different natural sources.不同天然来源的人表面活性剂蛋白 D 的结构和活性。
Am J Physiol Lung Cell Mol Physiol. 2020 Jul 1;319(1):L148-L158. doi: 10.1152/ajplung.00007.2020. Epub 2020 May 20.
4
Differential Ligand Binding Specificities of the Pulmonary Collectins Are Determined by the Conformational Freedom of a Surface Loop.肺凝集素的差异配体结合特异性由表面环的构象自由度决定。
Biochemistry. 2017 Aug 8;56(31):4095-4105. doi: 10.1021/acs.biochem.6b01313. Epub 2017 Jul 31.
5
The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo.肺凝集素N端结构域在体内表面活性剂结构、功能及稳态中的作用。
J Biol Chem. 2002 Jul 26;277(30):26971-9. doi: 10.1074/jbc.M110080200. Epub 2002 May 15.
6
Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A.重组人肺表面活性蛋白D和SP-D多聚体与甲型流感病毒的相互作用。
Am J Physiol. 1996 Nov;271(5 Pt 1):L753-62. doi: 10.1152/ajplung.1996.271.5.L753.
7
Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D.纠正Sftpd-/-小鼠的肺部异常需要表面活性蛋白D的胶原结构域。
J Biol Chem. 2006 Aug 25;281(34):24496-505. doi: 10.1074/jbc.M600651200. Epub 2006 Jun 20.
8
Accumulation of surfactant protein D in human pulmonary alveolar proteinosis.表面活性蛋白D在人肺泡蛋白沉积症中的蓄积
Am J Pathol. 1993 Jan;142(1):241-8.
9
Surfactant protein A and surfactant protein D variation in pulmonary disease.肺部疾病中表面活性蛋白A和表面活性蛋白D的变化
Immunobiology. 2007;212(4-5):381-416. doi: 10.1016/j.imbio.2007.01.003. Epub 2007 Feb 23.
10
S-nitrosylation of surfactant protein-D controls inflammatory function.表面活性蛋白-D的S-亚硝基化调控炎症功能。
PLoS Biol. 2008 Nov 11;6(11):e266. doi: 10.1371/journal.pbio.0060266.

引用本文的文献

1
Surfactant protein-D is an independent predictor of all-cause mortality in men with peripheral artery disease diagnosed by population-based screening.表面活性蛋白-D是通过基于人群的筛查诊断出的外周动脉疾病男性患者全因死亡率的独立预测指标。
Front Cardiovasc Med. 2025 May 20;12:1534779. doi: 10.3389/fcvm.2025.1534779. eCollection 2025.
2
Revisiting surfactant protein D: an immune surveillance molecule bridging innate and adaptive immunity.重新审视表面活性蛋白D:一种连接固有免疫和适应性免疫的免疫监视分子。
Front Immunol. 2024 Dec 17;15:1491175. doi: 10.3389/fimmu.2024.1491175. eCollection 2024.
3
Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study.
探索血浆表面活性蛋白-D(SP-D)水平升高与OSCAR基因表达之间的关联,作为慢性阻塞性肺疾病(COPD)患者的潜在生物标志物:一项横断面研究。
Front Pharmacol. 2024 Jul 18;15:1376394. doi: 10.3389/fphar.2024.1376394. eCollection 2024.
4
Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus.用于溶瘤病毒中最佳载体化的抗PD-L1单域抗体和肿瘤坏死因子超家族配体的设计与选择
Front Bioeng Biotechnol. 2023 Nov 15;11:1247802. doi: 10.3389/fbioe.2023.1247802. eCollection 2023.
5
Characterization of Oligomer Formation of Surfactant Protein-D (SP-D) Using AF4-MALLS.使用不对称流场流分馏-多角度激光光散射(AF4-MALLS)对表面活性蛋白D(SP-D)低聚物形成的表征
Curr Protein Pept Sci. 2022;23(12):862-873. doi: 10.2174/1389203724666221102111145.
6
Malondialdehyde Acetaldehyde-Adduction Changes Surfactant Protein D Structure and Function.丙二醛乙醛加合物改变表面活性蛋白 D 的结构和功能。
Front Immunol. 2022 May 20;13:866795. doi: 10.3389/fimmu.2022.866795. eCollection 2022.
7
A recipe for a good clinical pulmonary surfactant.一种好的临床用肺表面活性剂的配方。
Biomed J. 2022 Aug;45(4):615-628. doi: 10.1016/j.bj.2022.03.001. Epub 2022 Mar 8.
8
Commentary: Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.评论:模式识别蛋白:对抗冠状病毒的第一道防线。
Front Immunol. 2022 Jan 26;13:815168. doi: 10.3389/fimmu.2022.815168. eCollection 2022.
9
Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2.全长重组人 SP-D 结合并抑制 SARS-CoV-2。
Biomolecules. 2021 Jul 28;11(8):1114. doi: 10.3390/biom11081114.
10
Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem.表面活性蛋白 D 与支气管肺发育不良:一个解决老问题的新方法。
Respir Res. 2021 May 8;22(1):141. doi: 10.1186/s12931-021-01738-4.